Your browser doesn't support javascript.
loading
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.
Ebata, Satoshi; Yoshizaki, Ayumi; Fukasawa, Takemichi; Miura, Shunsuke; Takahashi, Takehiro; Sumida, Hayakazu; Asano, Yoshihide; Sato, Shinichi.
  • Ebata S; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yoshizaki A; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Fukasawa T; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Miura S; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Takahashi T; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Sumida H; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Asano Y; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Sato S; Department of Dermatology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
J Dermatol ; 46(11): 1006-1013, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31502326
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales / Ciclofosfamida / Rituximab / Inmunosupresores Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Pulmonares Intersticiales / Ciclofosfamida / Rituximab / Inmunosupresores Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article